A study shows elevated CFHR1 promotes immune complex buildup in kidneys, offering insights into disease mechanisms, enabling ...

Immunoglobulin A (IgA) nephropathy results from the accumulation of IgA-containing immune complexes (IgA-ICs) and aberrant ...

Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good afternoon, and welcome to today’s earnings call for Omeros Corporation. [Operator Instructions] Please be ...

Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs) in the glomerular mesangium, leading to mesangial ...

Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs ...

Q4 2025 Earnings Call March 31, 2026 4:30 PM EDTCompany ParticipantsGregory Demopulos - Co-Founder, Chairman, CEO ...

The ongoing GARDian3 study is designed to assess whether a single subretinal administration of OCU410ST can slow structural ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that data from the Phase 3 study of vilobelimab ...

GARDian3 trial enrollment and dosing completed (N=63) in less than nine monthsTopline results expected in 2Q27 with BLA to follow by ...

This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.

Update highlights platform evolution including RF sensing activation, SaverOne transaction, exploratory Liberia offshore initiative, Israeli subsidiary formation, and expansion into global defense and ...

A new deep-brain BCI from Tsinghua University uses the lateral ventricles to record neural signals. This "lantern" electrode ...